Sedentary LifestyleNCT07482995
Effects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults
A study testing Baduanjin exercise and General Health Education in people with Sedentary Lifestyle and Behavioral Intervention, run by China-Japan Friendship Hospital at 1 site in China.
Trial summary
The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are: 1. Does the Baduanjin program improve participants' cardiorespiratory fitness (measured as peak oxygen uptake)? 2. Read more about this study
- Who is it for?
- Ages 18 to 59 yearsHealthy volunteers can take part
- Conditions the study is for
- Sedentary Lifestyle, Behavioral Intervention
- What is being tested?
- Baduanjin exercise and General Health Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 208 participants
- Where
- 1 siteChina
- Study dates
- 30 Sep 2026to 10 Oct 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 59 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Adults aged 18 to 59 years
- Sedentary and physically inactive, defined as: (a) self-reported sitting time ≥ 8 hours per day, AND (b) not meeting the World Health Organization (WHO) recommended level of physical activity ( engaging in < 150 minutes of moderate-to-vigorous intensity physical activity per week, assessed by the International Physical Activity Questionnaire [IPAQ])
- In good general health as self-reported, and free from any known diseases
- Willing and able to provide written informed consent
Who cannot join
- Contraindications to cardiopulmonary exercise testing
- Currently participating in, or planning to participate within the next 3 months, in any other structured exercise or behavioral intervention program
- Pregnancy, lactation, or planning to become pregnant during the study period
- Inability to understand or comply with the study procedures
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029
Jingyi Ren, Doctor, +86 17367938350, 1220193509@qq.com
About this study
Official title: A Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Mechanisms of Baduanjin on Improving Health Outcomes in Sedentary Young and Middle-Aged Adults
The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are:
- Does the Baduanjin program improve participants' cardiorespiratory fitness (measured as peak oxygen uptake)?
- Does it improve their body composition, muscle strength, balance, and flexibility?
- Does it reduce their daily sitting time?
Read more
Researchers will compare the Baduanjin training group to a health education control group to see if Baduanjin is more effective in improving these health outcomes.
Participants will:
- Be randomly assigned to one of the two groups.
- If in the Baduanjin group, attend supervised group sessions and practice at home for 12 weeks.
- Complete a series of assessments at the beginning, middle, and end of the study, including fitness tests, body measurements, and questionnaires.
- Conditions
- Sedentary Lifestyle, Behavioral Intervention
- Being tested
- Baduanjin exercise, General Health Education
- Medical subject headings
- Sedentary Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Baduanjin exerciseBehavioural
A 12-week, standardized Baduanjin exercise program. Participants will complete 5 sessions per week, each lasting 60 minutes (including warm-up, Baduanjin practice, and cool-down). The program includes both supervised group sessions and guided home practice.
General Health EducationOther
Participants will receive general health education (including recommendations on physical activity types and duration), but will not be enrolled in any structured or supervised exercise program. They will be instructed to maintain their usual lifestyle.
| Study group | Role | What they receive |
|---|---|---|
| Baduanjin Training Group | Experimental | Participants in this group will receive a 12-week Baduanjin exercise program. The program consists of supervised group sessions combined with home-based practice, with a frequency of 5 sessions per week. Each session lasts 60 minutes, including warm-up, standardized Baduanjin practice, and cool-down. The Baduanjin exercises follow a standardized protocol. Receives: Behavioral: Baduanjin exercise |
| Health Education Control Group | Other | Participants in this group will receive general health education, which includes recommendations on physical activity types and duration (e.g., following the WHO guidelines). However, they will not be enrolled in any structured, supervised exercise program. They will be instructed to maintain their usual lifestyle throughout the study period. Receives: Other: General Health Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Peak Oxygen Uptake (VO₂peak) assessed by Cardiopulmonary Exercise Testing
Measured by Cardiopulmonary Exercise Testing (CPET).
Measured: at baseline and Week 13.
Secondary outcomes (47)
Change in Sit-and-Reach Distance
Assessed by the standard sit-and-reach test.
Measured: at baseline, Week 8, and Week 13.
Change in Active Range of Motion of the Shoulder, Hip, Knee, and Ankle joints assessed by Goniometry
Measured using a goniometer
Measured: at baseline, Week 8, and Week 13.
Change in Time Spent in Sedentary Behavior assessed by the International Physical Activity Questionnaire (IPAQ)
Measured: at baseline and Week 13.
Scores on the Exercise Benefits/Barriers Scale (EBBS)
The scale consists of two subscales: the Exercise Benefits Subscale (29 items) and the Exercise Barriers Subscale (14 items). The total score ranges from 43 to 172, with a higher score indicating a more positive perception towards exercise.
Measured: at baseline and Week 13
Change in Knee Extension Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during knee extension
Measured: at baseline, Week 8, and Week 13.
Change in Knee Extension Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal knee extension contractions.
Measured: at baseline, Week 8, and Week 13.
Change in Knee Extension Average Power assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13.
Change in Knee Extension Fatigue Index assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13.
Change in Knee Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Knee Flexion measured at a preset angular velocity
Measured: at baseline, Week 8, and Week 13
Change in Knee Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Knee Flexion contractions
Measured: at baseline, Week 8, and Week 13
Change in Knee Flexion Average Power assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Knee Flexion Fatigue Index assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Shoulder Flexion, measured at a preset angular velocity.
Measured: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Shoulder Flexion contractions
Measured: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Average Power assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Fatigue Index assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Shoulder Abduction , measured at a preset angular velocity
Measured: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Shoulder Abduction contractions
Measured: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Average Power assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Fatigue Index assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Elbow Extension Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Elbow Extension, measured at a preset angular velocity
Measured: at baseline, Week 8, and Week 13
Change in Elbow Extension Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Elbow Extension contractions
Measured: at baseline, Week 8, and Week 13
Change in Elbow Extension Average Power assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Elbow Extension Fatigue Index assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Elbow Flexion Peak Torque assessed by Isokinetic Dynamometry
Maximum torque generated during Elbow Flexion, measured at a preset angular velocity
Measured: at baseline, Week 8, and Week 13
Change in Elbow Flexion Total Work assessed by Isokinetic Dynamometry
Total work performed during repeated maximal Elbow Flexion contractions
Measured: at baseline, Week 8, and Week 13
Change in Elbow Flexion Average Power assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Elbow Flexion Fatigue Index assessed by Isokinetic Dynamometry
Measured: at baseline, Week 8, and Week 13
Change in Rhythmic Weight Shift (RWS) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Measured: at baseline, Week 8, and Week 13.
Change in Modified Clinical Test of Sensory Interaction on Balance (mCTSIB) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Measured: at baseline, Week 8, and Week 13.
Change in Sensory Organization Test (SOT) Composite Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Measured: at baseline, Week 8, and Week 13.
Change in Motor Control Test (MCT) Latency assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Measured: at baseline, Week 8, and Week 13.
Change in Limits of Stability (LOS) Score assessed by Computerized Dynamic Posturography
Measured using a computerized dynamic posturography system.
Measured: at baseline, Week 8, and Week 13.
Change in Muscle Mass assessed by Bioelectrical Impedance Analysis
Measured: at baseline and Week 13.
Change in Body Fat Percentage assessed by Bioelectrical Impedance Analysis
Measured: at baseline and Week 13.
Change in Fat-Free Mass assessed by Bioelectrical Impedance Analysis
Measured: at baseline and Week 13.
Change in Waist-to-Hip Ratio
Ratio of waist circumference to hip circumference
Measured: at baseline and Week 13.
Change in Center of Mass Sway Amplitude during Baduanjin Exercise assessed by 3D Motion Capture
Magnitude of anteroposterior and mediolateral displacement of the body's center of mass during static postures of Baduanjin, analyzed using a markerless 3D motion capture system
Measured: at baseline and Week 13
Change in Joint Range of Motion during Baduanjin Exercise assessed by 3D Motion Capture
Angular displacement of primary joints during the performance of Baduanjin movements, analyzed using a markerless 3D motion capture system.
Measured: at baseline and Week 13
Change in Center of Mass Height during Baduanjin Exercise assessed by 3D Motion Capture
Measured: at baseline and Week 13
Change in Integrated Electromyography (iEMG) during Baduanjin Exercise assessed by Surface Electromyography
Measured: at baseline and Week 13
Change in Root Mean Square (RMS) Amplitude during Baduanjin Exercise assessed by Surface Electromyography
Measured: at baseline and Week 13
Change in Glycemic Control Biomarkers
Fasting venous blood samples will be analyzed for indicators of glucose metabolism, such as glycated hemoglobin (HbA1c) and fasting insulin.
Measured: at baseline and Week 13.
Change in Lipid Profile
Fasting venous blood samples will be analyzed for indicators of lipid metabolism, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C).
Measured: at baseline and Week 13.
Change in Inflammatory and Neurotrophic Biomarkers
Fasting venous blood samples will be analyzed for inflammatory markers (e.g., high-sensitivity C-reactive protein [hs-CRP], interleukin-6 [IL-6], tumor necrosis factor-alpha [TNF-α]) and brain-derived neurotrophic factor (BDNF).
Measured: at baseline and Week 13.
Percentage of Prescribed Baduanjin Sessions Completed
Measured: Through study completion, up to Week 13.
Baduanjin Movement Quality Score assessed by Blinded Expert Review (100-point scale)
Score assessed by blinded experts using a standardized 100-point scoring rubric. Scores range from 0 to 100, with a higher score indicating better movement quality.
Measured: at Week 13
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2026
- Study start30 Sep 2026
- Primary completion30 Sep 2027 (estimated)
- Study completion10 Oct 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sedentary LifestyleStudies of the same condition, open and under way.
- More trials run by China-Japan Friendship HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 208 participants (estimated)
Sponsor and investigators
- Lead sponsor
- China-Japan Friendship Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jingyi Ren, China-Japan Friendship Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07482995
- Sponsor's protocol ID
- Shoufa 2024-1-4061
- Status last verified
- Nov 2026
- First submitted
- 24 Feb 2026
- Last updated
- 5 Nov 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Mechanisms of Baduanjin on Improving Health Outcomes in Sedentary Young and Middle-Aged Adults
- ClinicalTrials.gov ID
- NCT07482995
- Acronym / sponsor ID
- Shoufa 2024-1-4061
- Conditions
- Sedentary Lifestyle, Behavioral Intervention
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 208 participants (estimated)
- Lead sponsor
- China-Japan Friendship HospitalUniversity, hospital or other
- Study start
- 30 Sep 2026 (actual)
- Primary completion
- 30 Sep 2027 (estimated)
- Study completion
- 10 Oct 2027 (estimated)
- First posted
- 19 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are:
- Does the Baduanjin program improve participants' cardiorespiratory fitness (measured as peak oxygen uptake)?
- Does it improve their body composition, muscle strength, balance, and flexibility?
- Does it reduce their daily sitting time?
Researchers will compare the Baduanjin training group to a health education control group to see if Baduanjin is more effective in improving these health outcomes.
Participants will:
- Be randomly assigned to one of the two groups.
- If in the Baduanjin group, attend supervised group sessions and practice at home for 12 weeks.
- Complete a series of assessments at the beginning, middle, and end of the study, including fitness tests, body measurements, and questionnaires.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Baduanjin Training Group | Experimental | Behavioral: Baduanjin exerciseParticipants in this group will receive a 12-week Baduanjin exercise program. The program consists of supervised group sessions combined with home-based practice, with a frequency of 5 sessions per week. Each session lasts 60 minutes, including warm-up, standardized Baduanjin practice, and cool-down. The Baduanjin exercises follow a standardized protocol. |
| Health Education Control Group | Other | Other: General Health EducationParticipants in this group will receive general health education, which includes recommendations on physical activity types and duration (e.g., following the WHO guidelines). However, they will not be enrolled in any structured, supervised exercise program. They will be instructed to maintain their usual lifestyle throughout the study period. |
Who may qualify
- Ages
- 18 to 59 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Adults aged 18 to 59 years
- Sedentary and physically inactive, defined as: (a) self-reported sitting time ≥ 8 hours per day, AND (b) not meeting the World Health Organization (WHO) recommended level of physical activity ( engaging in < 150 minutes of moderate-to-vigorous intensity physical activity per week, assessed by the International Physical Activity Questionnaire [IPAQ])
- In good general health as self-reported, and free from any known diseases
- Willing and able to provide written informed consent
Key exclusion criteria (4 listed)
- Contraindications to cardiopulmonary exercise testing
- Currently participating in, or planning to participate within the next 3 months, in any other structured exercise or behavioral intervention program
- Pregnancy, lactation, or planning to become pregnant during the study period
- Inability to understand or comply with the study procedures
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Baduanjin exerciseA 12-week, standardized Baduanjin exercise program. Participants will complete 5 sessions per week, each lasting 60 minutes (including warm-up, Baduanjin practice, and cool-down). The program includes both supervised group sessions and guided home practice. | Behavioural | Baduanjin Training Group |
| General Health EducationParticipants will receive general health education (including recommendations on physical activity types and duration), but will not be enrolled in any structured or supervised exercise program. They will be instructed to maintain their usual lifestyle. | Other | Health Education Control Group |
Primary outcome
Change in Peak Oxygen Uptake (VO₂peak) assessed by Cardiopulmonary Exercise Testing
Time frame: at baseline and Week 13.
Measured by Cardiopulmonary Exercise Testing (CPET).
47 secondary outcomes
Change in Sit-and-Reach Distance
Time frame: at baseline, Week 8, and Week 13.
Change in Active Range of Motion of the Shoulder, Hip, Knee, and Ankle joints assessed by Goniometry
Time frame: at baseline, Week 8, and Week 13.
Change in Time Spent in Sedentary Behavior assessed by the International Physical Activity Questionnaire (IPAQ)
Time frame: at baseline and Week 13.
Scores on the Exercise Benefits/Barriers Scale (EBBS)
Time frame: at baseline and Week 13
Change in Knee Extension Peak Torque assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Total Work assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Extension Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13.
Change in Knee Flexion Peak Torque assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Total Work assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Knee Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Peak Torque assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Total Work assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Peak Torque assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Total Work assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Shoulder Abduction Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Peak Torque assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Total Work assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Extension Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Peak Torque assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Total Work assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Average Power assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Elbow Flexion Fatigue Index assessed by Isokinetic Dynamometry
Time frame: at baseline, Week 8, and Week 13
Change in Rhythmic Weight Shift (RWS) Score assessed by Computerized Dynamic Posturography
Time frame: at baseline, Week 8, and Week 13.
Change in Modified Clinical Test of Sensory Interaction on Balance (mCTSIB) Score assessed by Computerized Dynamic Posturography
Time frame: at baseline, Week 8, and Week 13.
Change in Sensory Organization Test (SOT) Composite Score assessed by Computerized Dynamic Posturography
Time frame: at baseline, Week 8, and Week 13.
Change in Motor Control Test (MCT) Latency assessed by Computerized Dynamic Posturography
Time frame: at baseline, Week 8, and Week 13.
Change in Limits of Stability (LOS) Score assessed by Computerized Dynamic Posturography
Time frame: at baseline, Week 8, and Week 13.
Change in Muscle Mass assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Body Fat Percentage assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Fat-Free Mass assessed by Bioelectrical Impedance Analysis
Time frame: at baseline and Week 13.
Change in Waist-to-Hip Ratio
Time frame: at baseline and Week 13.
Change in Center of Mass Sway Amplitude during Baduanjin Exercise assessed by 3D Motion Capture
Time frame: at baseline and Week 13
Change in Joint Range of Motion during Baduanjin Exercise assessed by 3D Motion Capture
Time frame: at baseline and Week 13
Change in Center of Mass Height during Baduanjin Exercise assessed by 3D Motion Capture
Time frame: at baseline and Week 13
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Nov 2026.
- Individual participant dataSharing planned: No
Related trials for Sedentary Lifestyle
Active, not recruiting
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
Physical Inactivity, Overweight and Obesity
Recruiting
Yoga vs. Stretching-Strengthening: Physical Fitness in Sedentary Young Adults
Sedentary Lifestlye, Exercise
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Recruiting
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
Obesity, Smoking Cessation
Not yet recruiting
Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 3)
Depression, Physical Inactivity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Baduanjin exercise and General Health Education in people with Sedentary Lifestyle and Behavioral Intervention, run by China-Japan Friendship Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jingyi Ren, M.D., Chief Physician (18600195099, renjingyi@cjfh.org.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Peak Oxygen Uptake (VO₂peak) assessed by Cardiopulmonary Exercise Testing (time frame: at baseline and Week 13.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.